The companys Dahej, Gujarat facility was approved by the USFDA without any observation in April 2017.On 11 July 2017, Mr. Yogesh M. Agrawal, Managing Director of Ajanta Pharma (APL) informed the ...

Gujarat Gas Ltd share price was down by -1. ... on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE ...

Gujarat Apollo Industries Ltd share price was ... on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

Ahmedabad: Gujarat's pharmaceutical sector is back in the spotlight, ending 2024 on a high note with double-digit growth for the first time in three years. With Rs 9,855 crore in moving annual ...

LONDON, Feb 4 (Reuters) - Britain's pharmacies regulator on Tuesday tightened rules for online pharmacies' prescribing obesity drugs, ordering them to make changes to prevent people from receiving ...

Gujarat's ambitious Bulk Drug Park in Bharuch at Jambusar is gaining significant traction, with over 20 pharmaceutical giants, including multinational corporations, expressing interest in the project.

Guj Terce Labs Standalone September 2024 Net Sales at Rs 13.30 crore, up 10.56% Y-o-Y Oct 29 2024 11:44 AM Guj Terce Labs Standalone June 2024 Net Sales at Rs 11.89 crore, up 10.93% Y-o-Y Aug 13 ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...